Association of inflammatory bowel disease with familial mediterranean fever in Turkish children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 56, Issue 5, 2013, Pages 498-502

  Beşer, Ömer F ^a   Kasapçopur, Özgür ^a   Çokuǧraş, Fügen Çullu ^a   Kutlu, Tufan ^a   Arsoy, Nil ^a   Erkan, Tülay ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Children; Familial Mediterranean fever; Inflammatory bowel disease; K695R mutation; MEFV mutation

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTICLE; BIOPSY; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; COLONOSCOPY; DISEASE ASSOCIATION; ENTERITIS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FOLLOW UP; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SCHOOL CHILD; TURKEY (REPUBLIC);

BIOPSY; CHILD; CHILD, PRESCHOOL; COLONOSCOPY; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MUTATION; TURKEY;

SACCHAROMYCES CEREVISIAE;

EID: 84877026873     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31827dd763     Document Type: Article

References (34)

1. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85
2. Savic S, Dickie LJ, Battellino M, et al. Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases. Curr Opin Rheumatol 2012;24:103-12
3. Lachmann HJ, Sengül B, Yavuz S, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006;45:746-50
4. Chae JJ, Komarow HD, Cheng J, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003;11:591-604
5. McDermott MF, Aksentijevich I. The autoinflammatory syndromes. Curr Opin Allergy Clin Immunol 2002;2:511-6
6. Bamias G, Nyce MR, De La Rue SA, et al. New concepts in the pathophysiology of inflammatory bowel disease. Ann İntern Med 2005;143:895-904
7. Potzi R, Walgrm M, Lochs H, et al. Diagnostic significance of endoscopic biopsy in Crohn' s disease. Endoscopy 1989;21:60-2
8. Lichtenberger GS, Flavell RA, Alexopoulou L. Innate immunity and apoptosis in IBD. Inflamm Bowel Dis 2004;10:58-62
9. McDermott MF. A common pathway in periodic fever syndromes. Trends Immunol 2004;25:457-60
10. Ayaz NA, Ozen S, Bilginer Y, et al. MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology 2009;48:23-5
11. Yurtcu E, Gokcan H, Yilmaz U, et al. Detection of MEFV gene mutations in patients with inflammatory bowel disease. Genet Test Mol Biomarkers 2009;13:87-90
12. Sari S, Egritas O, Dalgic B. The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy. Eur J Pediatr 2006;167:391-3
13. International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997;90:797-807
14. Yalçinkaya F, Open S, ö zçakar ZB, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology 2009;48:395-8
15. Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 2010;16:112-24
16. Main J, McKenzie H, Yeaman GR, et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 1988;297:1105-6
17. Sandborn WJ, Loftus EV JR, Colombel JF, et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2001;7:192-201
18. Winter HS, Landers CJ, Winkelstein A, et al. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis. J Pediatr 1994;124: 707-11
19. Bunn SK, Bisset WM, Main MJC, et al. Fecal calprotectin as a measure of disease avtivity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001;32:171-7
20. Tibble JA, Sigthorsson G, Foster R, et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362-6
21. Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol 2004;18:509-23
22. Pappa HM, Semrin G, Walker TR, et al. Pediatric inflammatory bowel disease. Curr Opin Gastroenterol 2004;20:333-40
23. Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 2003;88:995-1000
24. Tunca M, Akar, Onen F, et al. Familial Mediterranean fever (FMF) in Turkey: Results of a nationwide multicenter study. Medicine (Baltimore) 2005;84:1-11
25. Uslu N, Yüce A, Demir H, et al. The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children. Dig Dis Sci 2010;55:3488-94
26. Cattan D, Notarnicola C, Molinari N, et al. Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever. Lancet 2000;355:378-9
27. Fidder HH, Chowers Y, Lidar M, et al. Crohn disease in patients with familial Mediterranean fever. Medicine 2002;81:411-6
28. Chae JJ, Wood G, Masters SL, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 modulate IL-1 beta production. Proc Natl Acad Sci USA 2006;103: 9982-7
29. Giaglis S, Mimidis K, Papadopoulos V, et al. Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: Evidence for a potential disease-modifying effect? Dig Dis Sci 2006;51:687-92
30. Yildirim B, Tuncer C, Kan D, et al. MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients. Rheumatology 2011;31:859-64
31. Yilmaz E, Ozen S, Balci B, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001;9:553-5
32. Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001; 96:730-4
33. Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822-9
34. Molnár T, Farkas K, Nyári T, et al. Frequency and predictors of loss of response to infliximab or adalimumab in Crohn's disease after one-year treatment period -A single center experience. J Gastrointestin Liver Dis 2012;21:265-9